Tweenvest Stocks

Indegene Limited (NSEI: INDGN)

Health Care · Life Sciences Tools & Services · IN

Rs555.80

+0.24% today · -5.5% 1Y

Indegene Limited (NSEI: INDGN) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.40B and employs 4,687 people.

Over the last twelve months the share price has lost 5.5%, trading between 414.00 and 596.80.

Tweenvest scores Indegene Limited across four factors: quality 74/100, value 70/100, growth 85/100, dividend 43/100. Its strongest factor is growth.

INDGN price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.40B
Revenue (TTM)
$403.25M
P/E
33.46
EPS
16.61
Dividend yield
0.40%
Beta (5Y)
0.72
52-week high
Rs596.80
52-week low
Rs414.00
Avg volume (3M)
Shares outstanding
240.90M
Employees
4,687
Next earnings

About Indegene Limited

Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.

ISIN
INE065X01017
Founded
1998
Listed since
May 13, 2024
Exchange
National Stock Exchange of India
Currency
INR
CompanyMarket capPriceDay
Thermo Fisher Scientific Inc.NYSE: TMO$232.26B$628.15-0.09%
Danaher CorporationNYSE: DHR$151.82B$215.97+0.40%
WuXi AppTec Co., Ltd.SHSE: 603259$71.35BCN¥161.00+3.31%
Samsung Biologics Co.,Ltd.KOSE: A207940$51.75B1,551,000.00+0.19%
Lonza Group AGSWX: LONN$51.65BCHF593.80+1.02%
Agilent Technologies, Inc.NYSE: A$43.71B$154.77+0.87%
IQVIA Holdings Inc.NYSE: IQV$42.70B$259.42-0.32%
Waters CorporationNYSE: WAT$40.72B$414.44+0.90%

Browse every Life Sciences Tools & Services company →

Figures last refreshed Aug 18, 2026.